Vanda Pharmaceuticals downgraded by Jefferies with a new price target

2/25/22 4:56:52 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Jefferies downgraded Vanda Pharmaceuticals from Buy to Hold and set a new price target of $12.00 from $24.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VNDA

Date	Price Target	Rating	Analyst
10/31/2024	$18.00	Buy	H.C. Wainwright
7/11/2024	$11.00	Overweight	Cantor Fitzgerald
2/25/2022	$24.00 → $12.00	Buy → Hold	Jefferies